mammalian longevity study
搜索文档
Longevica Therapeutics Appoints Ex-Genentech Biotech Veteran Dr. Prasun Mishra as CEO to Advance World's Largest $13 Million Mammalian Longevity Study Toward Clinical Development
Businesswire· 2026-08-18 20:07
公司动态 - Longevica任命前基因泰克/罗氏高管Dr Prasun Mishra为首席执行官[1] - 该任命旨在推进公司一项价值1300万美元的哺乳动物长寿研究项目[1] - 该项目目标为向IND（新药临床研究申请）阶段开发迈进[1]
